<DOC>
	<DOCNO>NCT02066961</DOCNO>
	<brief_summary>The purpose study describe pattern disease management describe clinical outcome , well identify factor influence physician treatment decision include reason ( ) treatment choice trigger ( ) treatment change document healthcare resource utilization use manage treatment-related complication .</brief_summary>
	<brief_title>A Study Describe Patterns Care Outcomes Men Who Are High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy , Men With Castration-resistant Prostate Cancer Men With Metastatic Prostate Cancer</brief_title>
	<detailed_description>Each subject follow time enrollment minimum 3 year maximum 6 year death , whichever come first .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Diagnosis prostate adenocarcinoma Will receive new intervention time study entry , treatment : Biochemical failure initial curativeintent surgery ( radical prostatectomy ) radiotherapy ( externalbeam radiation therapy , brachytherapy , ) PSA double time one year less confirmed PSA â‰¥ 50 ng/mL ( 2 consecutive value ) within 6 month prior study entry ; Castrationresistant prostate cancer ; Metastatic prostate cancer initial diagnosis prostate cancer Prior treatment metastatic castrationresistant prostate cancer systemic chemotherapy Life expectancy &lt; 1 year due comorbidities</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>metastatic prostate cancer</keyword>
	<keyword>castration-resistant prostate cancer</keyword>
	<keyword>prostate cancer</keyword>
</DOC>